07 Nov 2026, 06:48 IST
Sai Life Sciences Limited
HDFC Securities · BUY · target INR 2,050
The report reiterates BUY on Sai Life Sciences with a revised TP of INR 2,050, citing 29% YoY EBITDA growth, capacity expansion plans, and strong sales growth visibility of 25% CAGR over FY26-29E.
From HSIE Results Daily 07 Nov 26 HSIE, written by HDFC Securities. Orivam summarised it; the view is HDFC Securities's, not Orivam's.
Open the original PDF →Research PDFs are often removed by the firms that publish them. The summary above is kept so this page still means something if that happens.